Cover Image

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice

Background Dose reduction (DR) of adalimumab, etanercept and ustekinumab has proven to be (cost-)effective in psoriasis patients with low disease activity. Further implementation is needed to establish application of DR for eligible patients. Objectives To evaluate the implementation of protocolized...

Full description

Saved in:
Bibliographic Details
Main Authors: L.S. van der Schoot (Author), J.J. Janssen (Author), M.T. Bastiaens (Author), A. de Boer-Brand (Author), C. Christiaansen-Smit (Author), D.N.H. Enomoto (Author), R. Hovingh (Author), R.A. Tupker (Author), M.M.B. Seyger (Author), L.M. Verhoef (Author), J.M.P.A. van den Reek (Author), E.M.G.J. de Jong (Author)
Format: Book
Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items